Clinical Trial

Assessment of an Intensive Motor Telerehabilitation Program for Stroke Patients

Study acronym: REACT-AVC
Recruiting
View on ClinicalTrials.gov →
Summary
Stroke is a major cause of motor disability, particularly hemiplegia, and its incidence is increasing as the population ages. Despite partial spontaneous recovery in the first three months, 80% of patients retain a motor deficit after six months, requiring intensive rehabilitation to maximize recovery. However, after hospitalization, access to intensive rehabilitation is limited, due to geographical and mobility constraints, and the lack of reimbursement for private occupational therapy. Telerehabilitation, using digital technologies, can overcome these difficulties by offering interactive, accessible rehabilitation at home. Studies show that its effectiveness is comparable to that of clinical rehabilitation. Our study therefore proposes to evaluate the feasibility and effects of a home-based telerehabilitation program using the MindMotion GO device (MindMaze). This 12-week program aims to provide an additional intensive dose of rehabilitation to the standard of care, with 300 minutes of weekly active therapy, planned and monitored remotely by a therapist.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-19; most recent amendment 2026-03-03.
Status change: Not Yet Recruiting → Recruiting 2026-03-03
Trial Details
NCT Number NCT07254195
Lead Sponsor Hospices Civils de Lyon
Conditions Stroke
Enrollment 51 participants
Start Date 2026-02-25
Primary Completion 2028-01-25 (estimated)
Study Completion 2028-01-25 (estimated)
Updated on ClinicalTrials.gov 2026-03-05